CollPlant Biotechnologies Book Value Per Share Growth & History (CLGN)
CollPlant Biotechnologies's book value per share was $0.47 for fiscal 2025.
View full CollPlant Biotechnologies company overviewCollPlant Biotechnologies annual book value per share history
| Fiscal year | Period ended | Book value per share | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $0.47 | -$0.70 | −59.60% |
| 2024 | 2024-12-31 | $1.18 | -$1.30 | −52.50% |
| 2023 | 2023-12-31 | $2.47 | -$0.41 | −14.25% |
| 2022 | 2022-12-31 | $2.89 | -$1.30 | −31.11% |
| 2021 | 2021-12-31 | $4.19 | $3.55 | +551.54% |
| 2020 | 2020-12-31 | $0.64 | -$0.08 | −10.82% |
| 2019 | 2019-12-31 | $0.72 | $0.69 | +2436.86% |
| 2018 | 2018-12-31 | $0.03 | -$0.00 | −8.33% |
| 2017 | 2017-12-31 | $0.03 | $0.02 | +109.20% |
| 2016 | 2016-12-31 | $0.01 | — | — |
CollPlant Biotechnologies quarterly book value per share
| Fiscal quarter | Period ended | Book value per share | Change | YoY change |
|---|---|---|---|---|
| Q1 2026 | 2026-03-31 | $0.34 | -$0.74 | −68.70% |
| Q4 2025 | 2025-12-31 | $0.47 | -$0.70 | −59.60% |
| Q3 2025 | 2025-09-30 | $0.73 | — | — |
| Q2 2025 | 2025-06-30 | $0.98 | -$0.83 | −45.66% |
| Q1 2025 | 2025-03-31 | $1.08 | — | — |
| Q4 2024 | 2024-12-31 | $1.18 | -$1.30 | −52.50% |
| Q2 2024 | 2024-06-30 | $1.81 | -$1.35 | −42.73% |
| Q4 2023 | 2023-12-31 | $2.47 | -$0.41 | −14.25% |
| Q2 2023 | 2023-06-30 | $3.16 | -$0.51 | −13.84% |
| Q4 2022 | 2022-12-31 | $2.89 | -$1.30 | −31.11% |
| Q2 2022 | 2022-06-30 | $3.67 | -$1.15 | −23.90% |
| Q4 2021 | 2021-12-31 | $4.19 | $3.55 | +551.54% |
| Q2 2021 | 2021-06-30 | $4.82 | $3.93 | +439.55% |
| Q4 2020 | 2020-12-31 | $0.64 | -$0.08 | −10.82% |
| Q2 2020 | 2020-06-30 | $0.89 | $0.73 | +445.00% |
| Q4 2019 | 2019-12-31 | $0.72 | $0.69 | +2436.86% |
| Q2 2019 | 2019-06-30 | $0.16 | -$0.65 | −79.88% |
| Q4 2018 | 2018-12-31 | $0.03 | $0.01 | +90.53% |
| Q2 2018 | 2018-06-30 | $0.81 | — | — |
| Q4 2017 | 2017-12-31 | $0.01 | — | — |
CollPlant Biotechnologies book value per share trends
Over the last five fiscal years, CollPlant Biotechnologies's book value per share decreased from $0.64 to $0.47, a change of -$0.17. The latest reported quarter, Q1 2026, shows $0.34.
What book value per share means
Book value per share estimates the common shareholders’ accounting equity represented by each share. It can help compare a company’s balance-sheet value over time, although market value can differ substantially from book value.
How book value per share is calculated
TickerStat calculates book value per share as SEC-reported common shareholders’ equity divided by reported period-end common shares. Preferred equity is subtracted when separately reported, and basic weighted-average shares are used only when period-end shares are unavailable. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review CollPlant Biotechnologies source filings ↗